Effect of coronary artery flow on left ventricular contractile dysfunction induced by brain death

冠状动脉血流对脑死亡所致左心室收缩功能障碍的影响

基本信息

  • 批准号:
    11671331
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Background : Massive catecholamine release after brain death is thought to be one of the most important causes to cardiac dysfunction after heart transplantation. However, the exact mechanism for cardiac failure in brain-dead heart has not been fully elucidated. The aim of this study was to investigate the response of coronary artery to vasodilator and their contribution to hemodynamic deterioration using canine brain death model.Methods: Brain death was induced by rapid inflation of a subdurally placed balloon catheter. Hemodynamic measurements including assessment of left ventricular contractility using pressure-volume relations and biochemical analysis of blood samples was performed in 7 dogs. Coronary flow reserve was assessed by endothelium-dependent (acetylcholine ; Ach) and -independent (sodium nitroprusside ; SNP) coronary vasodilation in 8 dogs.Results: Hyperdynamic response was observed transiently after induction of brain death followed by decreases in arterial pressure, cardiac output and coronary blood flow. Left ventricular contractility was deteriorated at 60-minute after brain death. Coronary flow reserve both by Ach and SNP were significantly impaired at 30- and 60-minute after brain death (Ach 3μg 320.5 % to 189.1 % and 202.8 % ; SNP 100μg 255.6 % to 145.8 % and 153.5 %). Coronary resistance ratios were significantly increased at 30- and, 60-minute after brain death.Conclusions : Impairement of coronary flow reserve and left ventricular function was observed in brain-dead canine heart. This impaired coronary circulation could be a disadvantage of preservation and recovery of cardiac dysfunction.
背景资料:脑死亡后大量儿茶酚胺释放被认为是心脏移植术后心功能不全的重要原因之一。然而,脑死亡心脏心力衰竭的确切机制尚未完全阐明。本研究的目的是探讨冠状动脉血管扩张剂的反应和血流动力学恶化的贡献使用犬脑death model.Methods:脑死亡引起的硬膜下放置的球囊导管的快速膨胀。在7只犬中进行血液动力学测量,包括使用压力-容积关系评估左心室收缩力和血液样品的生化分析。冠状动脉血流储备评估内皮依赖性(乙酰胆碱;乙酰胆碱)和非依赖性(硝普钠; SNP)的冠状动脉vasodilationin 8只犬。结果:高动力反应,观察到短暂的诱导脑死亡后,动脉压,心输出量和冠状动脉血流量下降。脑死亡后60分钟左心室收缩力下降。脑死亡后30分钟和60分钟,Ach和SNP均使冠状动脉血流储备明显受损(Ach 3μg分别为320.5%和202.8%,SNP 100μg分别为255.6%和145.8%和153.5%).结论:脑死亡犬心脏冠状动脉血流储备和左室功能均受损。这种受损的冠状动脉循环可能不利于心功能不全的保存和恢复。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MORITA Shigeki其他文献

MORITA Shigeki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MORITA Shigeki', 18)}}的其他基金

Fracture mechanism of textured polycrystalline magnesium alloys
织构多晶镁合金的断裂机理
  • 批准号:
    24760578
  • 财政年份:
    2012
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Cardiac Regeneration using 3-Dimensional Cardiac Tissue
使用 3 维心脏组织进行心脏再生
  • 批准号:
    22390267
  • 财政年份:
    2010
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The development of new strategy of heart preservation with. transfection of a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene
心脏保存新策略的制定。
  • 批准号:
    14571271
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Living with Spontaneous Coronary Artery Dissection: A multicentre, patient-informed investigation
自发性冠状动脉夹层的生活:一项多中心、患者知情的调查
  • 批准号:
    481005
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Development of nextgeneration cellular artificial blood vessels for coronary artery bypass surgery using bio-3D printer
使用生物 3D 打印机开发用于冠状动脉搭桥手术的下一代细胞人造血管
  • 批准号:
    23H02991
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
  • 批准号:
    10722515
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease
心血管事件的分子预测因素和慢性冠状动脉疾病的恢复力
  • 批准号:
    10736587
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - UNIVERSITY OF MINNESOTA FIELD CENTER.
年轻人冠状动脉风险发展 (CARDIA) 研究 - 明尼苏达大学实地中心。
  • 批准号:
    10901060
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - COORDINATING CENTER (CC)
年轻人冠状动脉风险发展 (CARDIA) 研究 - 协调中心 (CC)
  • 批准号:
    10901063
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Repetitive Stretch-Induced Myocardial Stiffening in Chronic Coronary Artery Disease
慢性冠状动脉疾病中反复牵拉引起的心肌硬化
  • 批准号:
    10588929
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Sex-differences in 5 year survival with percutaneous coronary intervention compared to coronary artery bypass graft surgery in patients with diabetes and multivessel disease
糖尿病和多支血管疾病患者经皮冠状动脉介入治疗与冠状动脉搭桥手术的 5 年生存率存在性别差异
  • 批准号:
    495441
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
DCAD - Developing better diagnostics for Coronary Artery Disease with novel AI-enhanced, ultra fast proteomics
DCAD - 利用新型 AI 增强型超快速蛋白质组学开发更好的冠状动脉疾病诊断方法
  • 批准号:
    10072712
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Collaborative R&D
ADAR mediated RNA editing is a causal mechanism in coronary artery disease
ADAR 介导的 RNA 编辑是冠状动脉疾病的因果机制
  • 批准号:
    10629687
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了